Human Genome Epidemiology Literature Finder
Records 1 - 17 (of 17 Records) |
Query Trace: Psychiatry and CYP2D6[original query] |
---|
[Individualized pharmacotherapy based on cytochrome P-450 (CYP) genotyping]. Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 2003 1 122 (29): 2781-3. Johansen Per Wiik, Bergan Stein, Rootwelt Helge, Kvittingen Eli Anne, Rugstad Hans Er |
CYP 2D6 polymorphism and antipsychotic therapy. Psychiatria Danubina 2008 Sep 20 (3): 369-71. Plesnicar Blanka Kores, Dolzan Vita, Zalar Boj |
Genetic variants of the drug-metabolizing enzyme CYP2D6 in Puerto Rican psychiatry patients: a preliminary report and potential implications for breast cancer patients. Puerto Rico health sciences journal 2010 Sep 29 (3): 299-304. González-Tejera Gloria, Gaedigk Andrea, Corey Sus |
Prolactin concentrations during aripiprazole treatment in relation to sex, plasma drugs concentrations and genetic polymorphisms of dopamine D2 receptor and cytochrome P450 2D6 in Japanese patients with schizophrenia. Psychiatry and clinical neurosciences 2012 Oct 66 (6): 518-24. Nagai Goyo, Mihara Kazuo, Nakamura Akifumi, Suzuki Takeshi, Nemoto Kenji, Kagawa Shoko, Ohta Ikuya, Arakaki Hajime, Kondo Tsuyos |
Relation between CYP2D6 Genotype, Phenotype and Therapeutic Drug Concentrations among Nortriptyline and Venlafaxine Users in Old Age Psychiatry. Pharmacopsychiatry 2016 Apr . Berm E, Kok R, Hak E, Wilffert |
Should a routine genotyping of CYP2D6 and CYP2C19 genetic polymorphisms be recommended to predict venlafaxine efficacy in depressed patients treated in psychiatric settings? Pharmacogenomics 2017 May . Taranu Adela, Colle Romain, Gressier Florence, El Asmar Khalil, Becquemont Laurent, Corruble Emmanuelle, Verstuyft Céli |
Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine. Combinatorial chemistry & high throughput screening 2018 6 21 (5): 374-380. Yenilmez Ebru Dundar, Tamam Lut, Karaytug Onur, Tuli Abdull |
Use of Pharmacogenetic Drugs by the Dutch Population. Frontiers in genetics 2019 7 10 567. Alshabeeb Mohammad A, Deneer Vera H M, Khan Amjad, Asselbergs Folkert |
High levels of several antipsychotics and antidepressants due to a pharmacogenetic cause: a case report. Pharmacogenomics 2019 6 20 (8): 567-570. Mian Paola, Somers Metten, Berg Maarten Ten, Cahn Winnie, Wilting Ingeborg, Schaik Ron v |
CYP2D6 Reduced Function Variants and Genotype/Phenotype Translations of CYP2D6 Intermediate Metabolizers: Implications for Personalized Drug Dosing in Psychiatry. Frontiers in pharmacology 2021 5 12 650750. Molden Espen, Juki? Marin |
Biochip-based approach for comprehensive pharmacogenetic testing. Drug metabolism and personalized therapy 2020 Dec . Ikonnikova Anna Yu, Filippova Marina A, Surzhikov Sergey A, Pozhitnova Victoria O, Kazakov Ruslan E, Lisitsa Tatiana S, Belkov Sergey A, Nasedkina Tatiana |
CYP2C19 and CYP2D6 Genotypes and Metabolizer Status Distribution in a Bulgarian Psychiatric Cohort. Journal of personalized medicine 2022 Jul 12 (7): . Ivanov Hristo Y, Grigorova Denitsa, Lauschke Volker M, Velinov Branimir, Stoychev Kaloyan, Kyosovska Gergana, Shopov Pet |
Clinical Impact of Functional CYP2C19 and CYP2D6 Gene Variants on Treatment with Antidepressants in Young People with Depression: A Danish Cohort Study. Pharmaceuticals (Basel, Switzerland) 2022 7 15 (7): . Thiele Liv S, Ishtiak-Ahmed Kazi, Thirstrup Janne P, Agerbo Esben, Lunenburg Carin A T C, Müller Daniel J, Gasse Christia |
Association of the Val66Met polymorphism of the BDNF gene and the deletional mutation of CYP2D6 gene with the prevalence and severity of depressive disorder in an Eastern Indian population. Indian journal of psychiatry 0 64 (3): 269-276. Haldar Somnath, Roy Suparna, Sen Santanu, Dasgupta Anindya, Ghosh Srij |
[Farmacogenetica in de psychiatrie; de huidige status quo]. Tijdschrift voor psychiatrie 2022 6 64 (5): 312-316. van Westrhenen R, Birkenhäger T |
Case Report: Pharmacogenetics Applied to Precision Psychiatry Could Explain the Outcome of a Patient With a New CYP2D6 Genotype. Frontiers in psychiatry 2022 3 12 830608. Marcos-Vadillo Elena, Carrascal-Laso Lorena, Ramos-Gallego Ignacio, Gaedigk Andrea, García-Berrocal Belén, Mayor-Toranzo Eduardo, Sevillano-Jiménez Alfonso, Sánchez Almudena, Isidoro-García María, Franco-Martín Manu |
Potential Impact of Pharmacogenomic Single Nucleotide Variants in a Rural Caucasian Population. The journal of applied laboratory medicine 2023 1 8 (2): 251-263. Williams Grace R, Tsongalis Gregory J, Lewis Lionel D, Barney Rachael E, Cook Leanne J, Aaron Geno K, Nerenz Robert |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: